| TGA Action ID |
RC-2026-RN-00556-1 |
| Type of Product |
Medical Device |
| Product Name/Description |
VITEK 2 System. An in vitro diagnostic medical device (IVD).
Software versions before V11.0 |
| ARTG Number |
287987 |
| Action Type |
Product Correction |
| Action Level |
Hospital |
| Hazard Classification |
Class II |
| Reason for the Action |
In 2022, during a historical review of VITEK 2 System software BIOART rules, bioMérieux identified four (4) discrepancies that could potentially affect the interpretation and reporting of antimicrobial susceptibility testing (AST) results in Australia. This was communicated in RC-2022-RN-00640-1.
This action is to provide a permanent corrective action for the identified BIOART rule discrepancies. |
| Instructions for Customers/Users |
As a permanent corrective action, bioMérieux has corrected the identified BIOART rule discrepancies in VITEK 2 Software Version 11.0.
bioMérieux team will contact customers in due course to arrange a mutually convenient time to update VITEK 2 Systems to Software Version 11.0. |
| Action Commencement Date |
23/07/2026 |
| Responsible Entity |
|
| Contact Information |
1800 333 421 - Helpdesk |